A group of 25 senators, led by Sen. Elizabeth Warren (D-MA), requested that HHS Sec. Xavier Becerra exercise march-in rights for Xtandi, a prostate cancer therapeutic. March-in rights give the government the right to take a license for itself if it helped to fund the product owner’s research.
If you are not happy with the results below please do another search
50 search results for: drugs in development
IC continues to be an area of significant unmet need, especially for critically ill patients in hospitals and patients with compromised immune systems. If approved, rezafungin will be the first new drug for the treatment of candidemia and invasive candidiasis in over a decade.
The company plans to expand its manufacturing capacity at the Research Triangle Park facility in North Carolina to support increased demand for its key diabetes drugs. It has been struggling to meet high demand for the drugs Trulicity and Mounjaro, especially due to production of multiple dosage forms for each of them.
Sanofi licensed CytoReason’s inflammatory bowel disease model in a multi-million dollar bid to identify new therapies for IBD and Crohn’s and colitis.
The trial involved administering two different types of a shot that uses a cold-causing virus to deliver genetic code of HIV, spread over four vaccination visits in a year. J&J used a similar technology for its COVID-19 vaccine.
Rykindo is a bi-weekly long-acting risperidone injection and is the first innovative therapy from Luye Pharma’s central nervous system product portfolio to be marketed in the United States.
Cambrian Biopharma announced that its latest pipeline company, Isterian Biotech, has emerged from stealth to develop first-in-class medicines to tackle aging.
Drugmakers are prioritizing complex biotech medicines over treatments that can be given as pills because recent U.S. legislation gives biologics a longer runway before becoming subject to government price limits, top industry executives said this week.
To further support pharma manufacturing partners and ensure launch delays are avoided, the company has deepened its expertise with REMS Strategy and Project Management solutions.
In a fireside chat at the 41st J.P. Morgan Healthcare Conference in San Francisco, CEO Rick Gonzalez said AbbVie is well-positioned for continued growth.